Vistin Pharma ASA (OSL:VISTN)
Norway flag Norway · Delayed Price · Currency is NOK
22.80
+0.10 (0.44%)
At close: Apr 28, 2026

Vistin Pharma ASA Ratios and Metrics

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,0119221,0511,033701859
Market Cap Growth
-6.56%-12.24%1.72%47.47%-18.47%11.06%
Enterprise Value
1,0059421,0531,034739809
Last Close Price
22.8020.8022.5520.6113.9717.14
PE Ratio
13.5712.3416.7522.66-34.56
Forward PE
-9.459.459.459.459.45
PS Ratio
2.252.042.452.362.303.08
PB Ratio
2.892.813.403.202.563.12
P/TBV Ratio
2.892.813.403.202.563.12
P/FCF Ratio
19.4314.8715.6714.21--
P/OCF Ratio
14.5311.729.7411.41-62.82
PEG Ratio
-1.721.721.721.721.72
EV/Sales Ratio
2.242.082.452.362.432.90
EV/EBITDA Ratio
8.988.2010.2012.19138.7118.91
EV/EBIT Ratio
11.3510.2012.3515.08-24.34
EV/FCF Ratio
19.3215.1815.7114.23--
Debt / Equity Ratio
0.000.010.00-0.180.01
Debt / EBITDA Ratio
0.000.010.01-7.950.03
Debt / FCF Ratio
0.010.020.02---
Net Debt / Equity Ratio
-0.02-0.04-0.04-0.080.18-0.12
Net Debt / EBITDA Ratio
-0.05-0.13-0.11-0.318.95-0.80
Net Debt / FCF Ratio
-0.11-0.24-0.17-0.36-0.641.88
Asset Turnover
1.041.101.091.080.820.85
Inventory Turnover
1.881.911.912.162.192.57
Quick Ratio
1.831.541.011.240.621.92
Current Ratio
2.962.582.242.431.353.36
Return on Equity (ROE)
21.88%23.42%19.85%15.29%-1.72%9.07%
Return on Assets (ROA)
12.79%14.00%13.53%10.58%-1.03%6.35%
Return on Invested Capital (ROIC)
20.98%23.54%22.33%17.30%-2.17%11.79%
Return on Capital Employed (ROCE)
23.30%25.60%26.60%20.50%-2.10%11.40%
Earnings Yield
7.37%8.11%5.97%4.41%-0.67%2.89%
FCF Yield
5.15%6.73%6.38%7.03%-10.68%-2.13%
Dividend Yield
6.61%7.21%5.54%4.85%5.37%4.38%
Payout Ratio
74.36%74.15%123.65%--89.17%
Total Shareholder Return
6.56%7.21%5.54%4.85%5.37%4.38%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.